TPST / Tempest Therapeutics, Inc. - Institutionelt ejerskab - Købere

Tempest Therapeutics, Inc.

Institutionelt og fondsejerskab - Købere

Større indehavere, der har åbnet nye stillinger i Tempest Therapeutics, Inc., omfatter Vanguard Capital Management Llc, Vanguard Fiduciary Trust Co, og Vanguard Global Advisers, LLC .

Denne side viser ændringer i ejerskabsstrukturen ved at notere institutioner, fonde og større aktionærer, der har øget deres beholdning eller åbnet nye positioner i den seneste rapporteringsperiode. Grønne rækker angiver nye positioner. Klik på linket ikon for at se den fulde transaktionshistorik.

Opgrader for at låse op for premium-data.

Fil dato Kilde Investor Type Gennemsnitlig pris
(Øst)
Aktier Δ Aktier
(%)
Rapporteret
Værdi
($1000)
Δ Værdi
(%)
Port Alloc
(%)
2026-02-12 13F CIBC Private Wealth Group, LLC 1.080 134,78 3 -25,00
2026-05-13 13F/A Jpmorgan Chase & Co 5 0
2026-05-15 13F Royal Bank Of Canada 27 237,50 0
2026-05-08 13F Vanguard Fiduciary Trust Co This fund is a listed as child fund of Vanguard Group Inc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value 68.908 113
2026-05-15 13F/A Vanguard Capital Management Llc 233.888 384
2026-05-15 13F Geode Capital Management, Llc 86.990 97,20 143 12,70
2026-05-08 13F Vanguard Global Advisers, LLC 168 0
2026-05-11 13F Citigroup Inc 8 0
2026-05-15 13F Tower Research Capital LLC (TRC) 2.790 110,57 5 33,33
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista